11 February 2025 

GenIP Plc

("GenIP" or the "Company")

GenIP Plc to Sponsor the AUTM 2025 Annual Meeting

GenIP plc, a technology business providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is delighted to announce its sponsorship and participation in the AUTM 2025 Annual Meeting, taking place from 2^nd to 5^th March 2025, in Maryland, USA.

AUTM, formerly known as the Association of University Transfer Managers, is a community of more than 3,000 members working in more than 800 universities, research centres, hospitals, businesses and government organisations around the globe.  AUTM is the leader in efforts to educate, promote and inspire professionals to support the development of academic research and innovation. This premier industry event is the world's largest gathering of technology transfer professionals from around the world, fostering collaboration, deal-making, and the exchange of insights on innovation and commercialisation.

The AUTM 2025 Annual Meeting is a key component of GenIP's broader marketing strategy. This event builds on GenIP's recent sponsorship of other impactful events, such as the XVIII National Brazilian Forum of Innovation and Technology Transfer Managers (FORTEC) and a major innovation event hosted by a leading research institution in Singapore, where GenIP forged relationships that have already translated into orders from new clients.

The AUTM Annual Meeting, and its other US based regional meetings throughout 2025, offer a unique opportunity to further expand GenIP's network and connect with influential professionals from both academia and industry. GenIP's presence at AUTM will play a vital role in driving  long-term growth and reinforcing GenIP's position as a leader in technology commercialisation.

Melissa Cruz, CEO of GenIP, commented:

"We are excited to be part of AUTM in 2025 and look forward to engaging with leaders in technology transfer. It's an incredible opportunity to showcase how GenIP's solutions are helping drive the commercialisation of groundbreaking technologies that have the potential to positively impact lives around the world."

Casey Annunziata, Business Development Manager of AUTM, commented:

"We are pleased to welcome GenIP as a sponsor at AUTM 2025. Their innovative approach to technology commercialisation and commitment to advancing the impact of emerging technologies align perfectly with our mission to foster collaboration and drive progress in the technology transfer community."

About the AUTM 2025 Annual Meeting

The AUTM Annual Meeting is a leading global platform for advancing knowledge in Intellectual Property, Technology Transfer, and Innovation. With over 9,000 face-to-face meetings and more than 90 educational sessions, this event plays a pivotal role in strengthening the technology transfer ecosystem by connecting professionals from universities, research institutions, corporations, and investment firms.

Learn more about the AUTM Annual Meeting here: https://autm.net/2025/home

For further information regarding GenIP, please visit www.genip.ai, or contact:

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulations would be disseminated as an RNS regulatory announcement and not on Reach.

Notes to Editors

About GenIP

GenIP provides generative artificial intelligence (GenAI) analytic services to help companies, research institutions and venture funds assess and commercialise new discoveries. GenIP combines expert human technical review with GenAI algorithms to provide insightful and verified services.

GenIP provides two complementary platform-based services:

1.   Invention Evaluator: Provides bespoke research reports that assess the market potential of new technological innovations and discoveries using AI-driven proprietary software; and

2.   Vortechs: which is an executive recruitment platform that through advanced machine learning algorithms and natural language processing technologies assists in matching technology organisations with experienced executives skilled in technology commercialisation.

The Company believes that its integrated GenAI service offerings will help organisations to evaluate and commercialise their technological innovations. 

Company Strategy

GenIP's goal is to be a leading Generative AI analytic services company. To achieve this, the Company has established three strategic pillars:

●     Organically grow Invention Evaluator and Vortechs' revenue through institutional and corporate connections as well as increase client pipeline through marketing, advertising and social media spend.

●     Expand the Generative AI service offerings within Invention Evaluator and Vortechs' to reach new customers and improve margins.

●     Bolt-on acquisitions of additional Generative AI services that are helpful to our clients and have demonstrated initial market traction. 

Forward looking statements

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-